A Glimpse Into The Expert Outlook On iRhythm Technologies Through 6 Analysts
Portfolio Pulse from Benzinga Insights
iRhythm Technologies (NASDAQ:IRTC) has been analyzed by 6 analysts, showing a range of opinions from bullish to bearish. The average 12-month price target is $122.83, with a high of $136.00 and a low of $108.00, indicating a slight increase from the previous average of $122.40. Analysts from firms including Needham, Truist Securities, Citigroup, and Morgan Stanley have updated their ratings and price targets, reflecting their views on the company's performance and market conditions. iRhythm Technologies, a digital healthcare company, has seen a revenue growth of 19.96% as of September 30, 2023, but faces challenges with below-average net margin, ROE, and ROA, despite a conservative debt-to-equity ratio.
January 08, 2024 | 7:01 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
iRhythm Technologies has a mixed outlook from analysts, with an average price target suggesting a modest upside. Revenue growth is strong, but profitability and asset utilization are below industry averages.
The mixed analyst ratings and slight increase in the average price target suggest a neutral short-term impact on iRhythm Technologies' stock price. The strong revenue growth is positive, but concerns about net margin, ROE, and ROA may temper investor enthusiasm. The conservative debt management is a positive sign, but the overall financial challenges indicated by the analysts could lead to cautious trading behavior.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100